The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

Researchers have found in a recent meta-analysis that belimumab is more effective than placebo in treating systemic lupus ...

Post-traumatic stress disorder (PTSD) is associated with an increased risk of developing systemic lupus erythematosus (SLE), with emerging evidence linking chronic psychological stress to immune ...

Long-term control of cardiovascular risk factors and sustained clinical remission help to mitigate the higher risk for ...

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

Procalcitonin levels greater than 0.9 ng/mL may be a useful biomarker for identifying bacterial infections among febrile patients with JSLE.

The annual 10km Lupus Awareness Fun Walk took place on May 31 in Mamelodi. We Also Sparkle and Waratwa foundations held the ...

Autolus Therapeutics plc delivers a breakthrough CAR-T therapy for B-ALL with strong safety/efficacy. Learn more about AUTL ...

Belimumab, a monoclonal antibody, added to standard therapy may treat a broader range of patients with lupus nephritis than previously appreciated.

Three years of remission from lupus nephritis appears to be the minimum period of time that protects against impaired kidney ...

Patients who develop LN within 1 to 5 years after SLE onset may face poorer renal outcomes compared with those who develop the disease earlier.

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...